This panel discussion features:
Christopher Peterson, Associate Director, Latham Biopharm Group;
Jason Slingsby, Chief Business & Corporate Development Officer, Oxford Biomedica; Dr. Ger Brophy, Executive Vice President of Biopharma Production, Avantor.

BioProcess Insider’s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends.

With a panel of industry experts, editor Dan Stanton will discuss recent M&A in the bioprocess space, bottlenecks within the manufacturing sector, the continued head- and tailwinds COVID-19 is placing on the sector, and the evolution of the cell and gene therapy landscape and what that means for the wider supply chains.

Watch now to hear first-hand insight into our industry.